Delivra Health Brands Inc.
  • Delivra’s (DHB) wholly-owned subsidiary, Dream Products USA Inc., has signed a sales and distribution agreement with Casey’s
  • Casey’s is a leading North American convenience store chain with over 2,400 locations
  • Dream Products has signed the agreement with 1, 2022 Casey’s General Stores, further expanding the company’s distribution in the U.S.
  • Delivra Health is an early-entry global cannabis company
  • Delivra Health Brands Inc. (DHB) remains unchanged, trading at C$0.025 per share at 1:06 pm ET

Delivra’s (DHB) wholly-owned subsidiary, Dream Products USA, has signed a sales and distribution agreement with Casey’s.

Casey’s is a leading North American convenience store chain with over 2,400 locations. Dream Products has signed a sales and distribution agreement dated November 1, 2022, with Casey’s General StoresCasey’s General Stores, further expanding the company’s distribution in the U.S.

Gord Davey, President and CEO of Delivra Health, commented on the news.

“Further to our growth objectives, our team has focused on the development of new emerging channel partners, which we have achieved through the signing of the agreement. This extends distribution to over 2,400 new Casey’s locations. These relationships, complemented by our existing partners and network in North America, will accelerate distribution, brand awareness and product trial.”

“This expanded network is exciting news as it will foster additional growth of the company’s existing CPG brand, Dream Water. It will set the company up for future success with our anticipated line extensions of both cannabis-infused and non-infused products.”

Delivra Health is an early-entry global cannabis company. It services the medical and recreational cannabis markets in Canada and internationally.

The company’s product portfolio features innovative brands like Dream Water and LivRelief. These products deliver relief from common everyday issues like chronic pain, anxiety, and sleeplessness.

Delivra Health Brands Inc. (DHB) remains unchanged, trading at C$0.025 per share at 1:06 pm ET.


More From The Market Online

What is behind the latest cannabis stock jump?

In a groundbreaking move, the U.S. federal administration is set to reclassify cannabis as a lower-risk substance.

Greenway Cannabis notches global cannabis accreditation

Greenway Greenhouse Cannabis (CSE:GWA) receives CUMCS-G.A.P and GACP certification for its cultivation facility in Ontario.

The Market Online’s Weekly Cannabis Report – April 26, 2024

Tilray has been garnering attention lately. Its subsidiary, Montauk Brewing Company, announced the return of Project 4:20 India Pale Ale

Buzz on the Bullboards: A recap of recent activity and stocks in focus

After a major sell-off, stock markets have been on edge, monitoring corporate earnings to gauge the direction of the economy.